IP Library Granted Patent US 10,638,941
Granted Patent B2
US 10,638,941 · App. 16/158,112 · Granted May 5, 2020

Discordance monitoring

Inventors: David E. Albert (Oklahoma City, OK); Omar Dawood (San Francisco, CA); Ravi Gopalakrishnan (San Francisco, CA)
Assignee: AliveCor, Inc.
A61B5/0205A61B5/681A61B5/7267A61B5/02405A61B5/02438A61B5/046A61B5/0464A61B5/04085A61B5/1118A61B2562/0219
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,638,941
App. No.
16/158,112
Granted
May 5, 2020
Kind
B2
Abstract

Described herein are systems, devices, and methods for cardiac monitoring. In particular, the systems, devices, and methods described herein may be used to conveniently sense the presence of an intermittent arrhythmia in an individual. The systems, devices, and methods described herein may be further configured to sense an electrocardiogram.

Claims (37)

1. A method of cardiac monitoring, comprising:

sensing an activity level of a user with a first sensor on a smartwatch worn by the user;

when the activity level is resting, sensing a heart rate parameter of the user with a second sensor on the smartwatch;

determining, by a processing device, that a discordance is present between the activity level value and the heart rate parameter;

based on the presence of the discordance, indicating to the user, using the smartwatch, a possibility of an arrhythmia being present; and

receiving electric signals of the user from an electrocardiogram sensor (“ECG”) on the smartwatch to confirm a presence of the arrhythmia, wherein the ECG sensor comprises a first electrode and a second electrode.

2. The method according to claim 1 , wherein the heart rate parameter comprises an indication of a heart rate variability, and wherein the arrhythmia is atrial fibrillation.

3. The method according to claim 1 , wherein the heart rate parameter comprises an indication of a heart rate variability and a heart rate value, and wherein the arrhythmia is atrial fibrillation.

4. The method according to claim 1 , wherein the heart rate parameter comprises an indication a heart rate value, and wherein the arrhythmia is atrial fibrillation.

5. The method according to claim 1 , wherein indicating to the user further comprises: instructing the user to record an ECG using the smartwatch.

6. The method according to claim 1 , wherein the arrhythmia is selected from a group consisting of atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia.

7. The method according to claim 1 , wherein the heartrate parameter is a PPG signal.

8. The method according to claim 7 , wherein the heart rate parameter is a heartrate variability (“HRV”) value, wherein the HRV value is derived from the PPG signal.

9. The method according to claim 7 , wherein the heart rate parameter is a heartrate, wherein the heartrate is derived from the PPG signal.

10. The method according to claim 1 further comprising:

displaying an ECG rhythm strip from the electric signals on the smartwatch.

11. The method according to claim 1 , wherein the first electrode is located on the smartwatch in a location where the first electrode contacts a first side of the user's body while the user wears the smartwatch, and the second electrode is located on the smartwatch in a location where the user must actively contact the second electrode with a second side of the user's body opposite from the first side.

12. A smartwatch, comprising:

a processor;

a first sensor configured to sense an activity level value of a user, wherein the first sensor is coupled to the processor;

a photoplethysmogram (“PPG”) sensor configured to sense a heart rate parameter of the user when the activity level value is resting, wherein the PPG sensor is coupled to the processor;

an electrocardiogram (“ECG”) sensor configured to sense electrical signals of a heart, wherein the ECG sensor comprises a first electrode and a second electrode, and wherein the ECG sensor is coupled to the processor; and

a non-transitory computer readable storage medium encoded with a computer program including instructions executable by the processor to cause the processor to:

determine if a discordance is present between the activity level value of the user and the heart rate parameter of the user;

based on the presence of the discordance, indicate to the user a possibility of an arrhythmia being present; and

receive electric signals of the user from the ECG sensor to confirm the presence of the arrhythmia.

13. The smartwatch or wristlet according to claim 12 , wherein the heart rate parameter comprises an indication of a heart rate variability, and wherein the arrhythmia is atrial fibrillation.

14. The smartwatch or wristlet according to claim 12 , wherein the heart rate parameter comprises an indication of a heart rate variability and a heart rate value, and wherein the arrhythmia is atrial fibrillation.

15. The smartwatch or wristlet according to claim 12 , wherein the heart rate parameter comprises an indication of a heart rate value, and wherein the arrhythmia is atrial fibrillation.

16. The smartwatch or wristlet according to claim 12 , wherein indicating to the user further comprises: instructing the user to record an ECG using the ECG sensor.

17. The smartwatch or wristlet according to claim 12 , wherein the arrhythmia is selected from a group consisting of atrial fibrillation, supraentricular tachycardia, and ventricular tachycardia.

18. The smartwatch according to claim 12 , wherein the heart rate parameter is a PPG signal.

19. The smartwatch according to claim 18 , wherein the heart rate parameter is a heartrate variability (“HRV”) value, wherein the HRV value is derived from the PPG signal.

20. The smartwatch according to claim 18 , wherein the heart rate parameter is a heartrate, wherein the heartrate is derived from the PPG signal.

21. The smartwatch according to claim 12 , the processor further to: display an ECG rhythm strip from the electric signals.

22. The smartwatch according to claim 12 , wherein the PPG sensor is located on a back of the smartwatch.

23. The smartwatch according to claim 12 , wherein the first electrode is located on the smartwatch where the first electrode contacts a first side of the user's body while the user wears the smartwatch, and the second electrode is located on the smartwatch where the user must actively contact the second electrode with a second side of the user's body opposite from the first side.

Assignments (4)
SECURITY INTEREST Recorded Jun 24, 2026
From: ALIVECOR, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 075813/0343 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2020
From: WANG, FEI; THOMSON, EUAN; ABUZEID, IMAN
To: ALIVECOR, INC.
Reel/Frame 054246/0621 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2020
From: DAWOOD, OMAR; GOPALAKRISHNAN, RAVI
To: ALIVECOR, INC.
Reel/Frame 051871/0990 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2019
From: ALBERT, DAVID E.
To: ALIVECOR, INC.
Reel/Frame 050768/0120 →
Continuity (4)
Continuation 15656745 · Jul 21, 2017
Continuation 15154849 · May 13, 2016
Provisional Application 62161092 · May 13, 2015
Related Publication 20190104948A1 · Apr 11, 2019
Cited By (1)
US 12,658,319